Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2024-07-26 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Bilan semestriel du contrat de liquidité au 28/06/2024
Regulatory Filings Classification · 99% confidence The document is titled "COMMUNIQUE DE PRESSE" and details the semi-annual balance sheet ("Bilan semestriel") of a liquidity contract managed by a broker (Gilbert Dupont) as of June 28, 2024. It reports the number of shares and cash balance in the liquidity account, along with trading volumes (purchases and sales) during the first half of 2024. This type of regular update concerning market making or liquidity provision activities is typically classified as a general regulatory announcement or a specific filing related to share transactions/capital management. Since it is a press release announcing the status of a liquidity contract, it is not a full financial report (10-K, IR) or a specific insider trade report (DIRS). It is most closely related to share activity or a general regulatory disclosure. Given the options, it fits best under general Regulatory Filings (RNS) as a specific, periodic disclosure that doesn't match the other precise categories like DIV, CAP, or DIRS, although it touches upon share activity. However, since it is a specific report on share transactions related to market making, it could also be argued as a form of 'Transaction in Own Shares' (POS) if the liquidity contract involves the company buying/selling its own stock, but RNS is a safer general classification for periodic, non-standard regulatory updates.
2024-07-26 French
Global Bioenergies devient membre du GIFAS
Regulatory Filings Classification · 100% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces that Global Bioenergies has joined GIFAS (Groupement des Industries Françaises Aéronautiques et Spatiales). This is a general announcement regarding a corporate development (membership in an industry group) and does not fit the specific definitions for financial reports (10-K, IR, ER), capital changes (CAP, SHA), management changes (MANG), or shareholder votes (DVA). Since it is a general corporate announcement that doesn't fit the highly specific categories like Director's Dealing, Dividend Notice, or M&A, it falls best under the general regulatory/corporate announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements, or potentially LTR if it were about legal matters, but it is not. Given the nature of a press release announcing industry affiliation, RNS is the most appropriate general classification.
2024-07-16 French
Global Bioenergies becomes a member of GIFAS
Regulatory Filings Classification · 100% confidence The document is a 'PRESS RELEASE' announcing that Global Bioenergies has joined GIFAS (Groupement des Industries Françaises Aéronautiques et Spatiales) and its StartAir club. This is a general corporate announcement regarding industry participation and strategic alignment, not a formal financial filing (like 10-K, ER, or IR). It does not fit the specific categories for management changes (MANG), financing (CAP), dividends (DIV), or insider trading (DIRS). Since it is a general, non-financial regulatory/industry announcement that doesn't fit the other specific categories (like AGM-R, CT, LTR, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category.
2024-07-16 English
Décarbonation du secteur aérien : Global Bioenergies étend son procédé technologique à la production de e-SAF
Regulatory Filings Classification · 100% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces a significant technological development by Global Bioenergies regarding the extension of its process to produce e-SAF (Sustainable Aviation Fuel) using acetic acid, highlighting technical specifications (95% selectivity) and regulatory context (ReFuelEU Aviation). This format—a formal announcement detailing recent operational or strategic news, often including quotes from management and partners—is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it is not a full financial report (10-K, IR), a transcript (CT), or a specific regulatory filing like DIRS or DIV, and it focuses on business/technology updates rather than just financial highlights (ER), it best fits the category of a general corporate announcement or news release. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a press release that doesn't fit a more specific operational category like M&A (TAR) or Capital Change (CAP). However, since it is a press release announcing a major strategic/technological step, it often functions similarly to an Earnings Release (ER) in terms of market communication, but ER is usually strictly about financial results. Given the content is a major announcement about technology and market positioning, and it is not a short notice about another report (RPA), RNS is the safest general classification for a press release not covered elsewhere. Upon review, this is a major corporate announcement, not a routine regulatory filing. Since there is no specific 'Press Release' code, and it's not a financial results summary (ER), RNS serves as the general announcement category.
2024-07-10 French
Decarbonizing the aviation sector: Global Bioenergies extends its technological process to the production of e-SAF
Regulatory Filings Classification · 100% confidence The document is explicitly titled 'PRESS RELEASE' and announces a technological breakthrough regarding Sustainable Aviation Fuels (SAF) and e-SAF production, including technical details, market context (ReFuelEU Aviation regulation), and quotes from the CEO and a partner (SkyNRG). This format—a formal announcement of significant business/technology news intended for immediate public release—is characteristic of an Earnings Release (ER) or a general regulatory/corporate announcement. Since it is not a full financial report (10-K, IR), a transcript (CT), or a specific shareholder/director filing, it best fits the category for initial financial/corporate news dissemination. Given the content focuses on a major operational/strategic development rather than just quarterly numbers, it leans towards a general corporate announcement. However, in the context of financial filings, press releases detailing operational milestones that impact future earnings are often categorized as Earnings Releases (ER) if they contain key performance indicators or strategic updates, or RNS if they are purely regulatory/miscellaneous. Since this is a significant, time-sensitive announcement about a new process and market positioning, it functions as a key corporate update. Given the options, 'ER' (Earnings Release) is often used broadly for major results/updates, but 'RNS' (Regulatory Filings) serves as the best general corporate announcement fallback when the content isn't strictly earnings-focused but is a public disclosure. Since this is a press release announcing a major technological step and market strategy, and it doesn't fit the specific financial report types, RNS is the most appropriate general disclosure category.
2024-07-10 English
Avancement du projet d’usine dédiée à la cosmétique : achèvement de la phase d’avant-projet sommaire et succès de la campagne de tests associée
Capital/Financing Update Classification · 95% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces the successful completion of the preliminary engineering phase ('Avant-Projet Sommaire' or APS) for a new cosmetics plant, including CAPEX figures (€65 million) and project timelines (mid-2027 commissioning). It also mentions successful process validation tests. This type of announcement, detailing project milestones, financing implications (CAPEX), and operational progress, is characteristic of a corporate update that is not a full financial report (like 10-K or IR) or a formal earnings release (ER). Since it discusses significant capital expenditure and project financing/structure updates, the most fitting category is 'Capital/Financing Update' (CAP). It is too detailed for a simple 'Regulatory Filing' (RNS) and does not fit the definitions for AGM-R, AR, MANG, CT, DVA, DLST, DIRS, ER, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Given the focus on CAPEX and project financing structure, CAP is the best fit.
2024-05-29 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.